This company has been marked as potentially delisted and may not be actively trading. Fusion Pharmaceuticals (FUSN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock FUSN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Fusion Pharma Stock Price HistoryMay 24, 2025 | investing.comAstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4B as Firm Expands Cancer PipelineFebruary 20, 2025 | investopedia.comFusion Finance Ltd (FUSN)November 4, 2024 | investing.comJapan start-up aims to launch world's first steady-state fusion reactor in 2034August 31, 2024 | msn.comFusion Pharma (FUSN) Earnings Dates & ReportsAugust 7, 2024 | investing.comAvidity Partners Management LP Increases Holdings in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)June 11, 2024 | marketbeat.comSuperstring Capital Management LP Takes $440,000 Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)June 10, 2024 | marketbeat.comAcquisition of Fusion Pharmaceuticals CompletedJune 4, 2024 | prnewswire.comFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of "Hold" by AnalystsJune 4, 2024 | marketbeat.comFusion Pharmaceuticals (NASDAQ:FUSN) Sets New 12-Month High at $21.60May 31, 2024 | marketbeat.comFusion Pharmaceuticals Receives Final Court Order Approving ArrangementMay 31, 2024 | prnewswire.comFusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume IncreaseMay 30, 2024 | marketbeat.comFusion Pharmaceuticals Shareholders Approve Acquisition by AstraZenecaMay 29, 2024 | prnewswire.comJump Financial LLC Invests $828,000 in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)May 20, 2024 | marketbeat.comFusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerMay 9, 2024 | prnewswire.comFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSNMay 9, 2024 | businesswire.comQ2 2024 EPS Estimates for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Boosted by William BlairMay 9, 2024 | marketbeat.comFUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024May 7, 2024 | investorplace.comFusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program UpdatesMay 7, 2024 | prnewswire.comFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Sees Significant Drop in Short InterestMay 1, 2024 | marketbeat.comFusion Pharmaceuticals (NASDAQ:FUSN) Hits New 12-Month High at $21.56May 1, 2024 | marketbeat.comJennison Associates LLC Makes New Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)April 27, 2024 | marketbeat.comTop 4 Health Care Stocks That May Plunge This MonthApril 26, 2024 | msn.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Laboratory (LH), Fusion Pharmaceuticals (FUSN) and Integer Holdings (ITGR)April 26, 2024 | markets.businessinsider.comFusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim OrderApril 25, 2024 | prnewswire.comFusion Pharmaceuticals Inc Ordinary SharesApril 19, 2024 | morningstar.comMFederated Hermes Inc. Acquires 202,364 Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)April 19, 2024 | marketbeat.comFusion Pharmaceuticals Inc. (FUSN) Stock Moves -0.09%: What You Should KnowApril 17, 2024 | finance.yahoo.comTD Cowen Downgrades Fusion Pharmaceuticals (FUSN)April 17, 2024 | msn.comHealthInvest Partners AB Makes New Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)April 16, 2024 | marketbeat.comFusion Pharmaceuticals (NASDAQ:FUSN) Earns "Hold" Rating from TD CowenApril 16, 2024 | marketbeat.comLeerink Partnrs Analysts Cut Earnings Estimates for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)April 12, 2024 | marketbeat.comFusion Pharmaceuticals Inc. (NASDAQ:FUSN) is definitely on the radar of institutional investors who own 46% of the companyApril 11, 2024 | finance.yahoo.comFusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024April 9, 2024 | finance.yahoo.comFusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024April 9, 2024 | prnewswire.comFusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 12-Month High at $21.55April 4, 2024 | marketbeat.comGenmab Buys ProfoundBio for $1.8B to Boost Oncology PortfolioApril 3, 2024 | msn.comFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Short Interest Down 8.3% in MarchApril 2, 2024 | marketbeat.comWhat Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for InvestorsMarch 28, 2024 | msn.comINVESTIGATION: The M&A Class Action Firm Announces an Investigation of Fusion Pharmaceuticals Inc. - FUSNMarch 26, 2024 | prnewswire.comFusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 1-Year High at $21.32March 25, 2024 | marketbeat.comYarbrough Capital LLC Acquires Shares of 76,872 Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)March 24, 2024 | marketbeat.comFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Expected to Earn FY2023 Earnings of ($1.36) Per ShareMarch 22, 2024 | marketbeat.comFY2026 EPS Estimates for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Raised by AnalystMarch 21, 2024 | marketbeat.comFusion Pharmaceuticals (NASDAQ:FUSN) Downgraded by Bloom BurtonMarch 21, 2024 | marketbeat.comFUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023March 20, 2024 | msn.comFusion Pharmaceuticals: Hold Rating Justified Amid Acquisition and Radiopharmaceutical Market DynamicsMarch 20, 2024 | markets.businessinsider.comKuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to Contact Law FirmMarch 20, 2024 | stockhouse.comFusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program UpdatesMarch 20, 2024 | finance.yahoo.comUnveiling 11 Analyst Insights On Fusion PharmaceuticalsMarch 20, 2024 | markets.businessinsider.com Get Fusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FUSN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FUSN Media Mentions By Week FUSN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FUSN News Sentiment▼0.000.92▲Average Medical News Sentiment FUSN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FUSN Articles This Week▼00▲FUSN Articles Average Week Get the Latest News and Ratings for FUSN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Fusion Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Prime Medicine News Protalix BioTherapeutics News Inhibikase Therapeutics News Invizyne Technologies News CEL-SCI News ZIVO Bioscience News Cortexyme News AlloVir News AIM ImmunoTech News NKGen Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FUSN) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
